Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 45Unknown 15Recruiting 11Terminated 9Withdrawn 5Active not recruiting 5Not yet recruiting 4Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 73Breast Neoplasms 70Colorectal Neoplasms 39Prostatic Neoplasms 37Carcinoma, Non-Small-Cell Lung 26Lung Neoplasms 25Stomach Neoplasms 20Carcinoma, Hepatocellular 20Uterine Cervical Neoplasms 19Pancreatic Neoplasms 15Anxiety Disorders 15Leukemia, Myeloid, Acute 14Hematologic Neoplasms 13Colonic Neoplasms 13Brain Neoplasms 13Urinary Bladder Neoplasms 12Lymphoma, Follicular 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Head and Neck Neoplasms 11Esophageal Neoplasms 10Diabetes Mellitus 10Ovarian Neoplasms 9Melanoma 9Liver Neoplasms 9Sarcoma 8Rectal Neoplasms 8Pulmonary Disease, Chronic Obstructive 8Multiple Myeloma 8Esophageal Squamous Cell Carcinoma 8Disease 8

Interventions

epigallocatechin gallate 1Sodium Chloride 1Catechin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Radiodermatitis × Clear all
NCT07149506 2025-09-08

OCTOPUS-RD

Universidad de Guanajuato

Phase 3 Enrolling by invitation
162 enrolled

Fibrosis, Radiodermatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡